与NASH/NAFLD相关的肝细胞癌:额外的负担
Doina Georgescu1, Daniel Florin Lighezan1, Ciprian Ilie Rosca1
1Department of Internal Medicine I-Medical Semiotics I, Centre for Advanced Research in Cardiovascular Diseases and Hemostaseology, "Victor Babeș" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timișoara, Romania.
肝细胞癌 (HCC),通常与非酒精性脂肪性肝病 (NAFLD) 相关,可能是偶然发现. 通过腹部超声波进行早期查对于肥胖和脂质不良症患者至关重要,特别是那些患有NASH的患者.
科学领域:
- 肝病学和瘤学 肝病学和瘤学
- 代谢综合征和肝脏疾病
背景情况:
- 肝细胞癌 (HCC) 发病率正在上升,与代谢综合征,肥胖,脂质不良和2型糖尿病有关.
- 非酒精性脂肪肝 (NAFLD) 是一个关键的中间体,可能通过遗传和环境因素发展为HCC.
- HCC通常是晚期诊断的,通常是偶然发现.
研究的目的:
- 在患有肥胖和失脂症的患者中呈现偶然诊断的,积极的HCC病例.
- 突出非酒精性脂肪肝炎 (NASH) 和高级HCC之间的关联.
- 强调早期诊断和定期查风险人群的重要性.
主要方法:
- 一名41岁的男性患有肥胖,脂质不良和最近的COVID-19病例报告.
- 诊断工具包括腹部超声波,点剪波弹性图像,磁共振成像和组织病理学.
- 确定了瘤分期 (TNM) 和分化 (G3).
主要成果:
- 偶然发现了一种与NASH相关的大型,侵袭性HCC (IVA阶段,差异化G3).
- 患者出现疲劳和消化不良,最初被误认为是COVID后综合征.
- 由于副作用,Sorafenib的治疗被中止,导致疾病的迅速进展和死亡率.
结论:
- 与NASH相关的HCC通常是偶然或在晚期被诊断出来的.
- 定期进行腹部超声波查对于患有肥胖,失脂症和NASH的人来说至关重要.
- 由于潜在的长期影响,COVID-19后症状需要仔细调查.
更多相关视频
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
相关概念视频
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
lncRNA - Long Non-coding RNAs
